chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: arms hurting; Lymph nodes hurting on the left side; chills in which she is hot and cold and she couldn't get warm at first and then she is cold; high blood pressure/blood pressure was high 190/116; big toes hurting; nausea; dizziness; feeling weakness legs/Leg feeling weak; This is a spontaneous report from a contactable other HCP reporting for herself.  A 72-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: CJ1686), via an unspecified route of administration in the right arm on 28Dec2020 15:00 at single dose for COVID-19 immunisation.  Medical history included breast cancer on the left side, hypertension, hiatal hernia, glaucoma, heart disease, hypertension, lymphadenectomy (lymph nodes being taken out was about 20 years before) and headache from 27Dec2020. She was working Sunday into Monday morning and she went to the Director of Nursing, and said she has a Headache on the left side of the temple, and so she went to eye doctor, and he had a test order ESR and so she has a hemorrhage in the left eye, and show she doesn't know if this could be bringing on some of the side effects she was speaking about, like the nausea and the migraine. She has had No positive test for COVID prior to the vaccine, she must have had about 20 tests and all were negative. She has not had any Antibody tests. She had pneumonia vaccine maybe in the last 5-3 years and flu vaccine in Oct2020 and she experienced achy arm. On 28Dec2020 the patient experienced leg feeling weak (about 15 minutes after injection), nauseous at 21:00, dizziness. On 29Dec2020 the patient experienced arm hurting (in the morning), lymph nodes hurting on the left side, chills, blood pressure was high 190/116, big toes hurting. The patient was calling to ask if these side effects she was experiencing were normal. On 29Dec2020 the patient underwent ESR with unknown results. The patient reported that her arm hurting began on 29Dec2020 in the morning. The breast cancer diagnosis was prior to the vaccine as well as her lymph nodes being taken out was about 20 years ago. Her Lymph nodes hurting on the left side started on 29Dec2020 in the morning. Her Leg feeling weak started right after the injection, about 15 minutes after on 28Dec2020. The chills started on 29Dec2020 in the morning in which she couldn't get warm. Her feeling nauseous started on 28Dec2020 in the evening like 9 PM. The Temperature 98.1 was her current temperature taken right before the call, as well as her blood pressure. Her feeling dizzy started after getting vaccine on 28Dec2020, she was fine to drive home, but then again on 29Dec2020 in the morning she felt it also. Her legs felt funny like rubbery. The big toes hurting started an hour before, on 29Dec2020 it woke her up since it was jabbing. The outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate, Heart rate increased, Palpitations, Pruritus
Clinical narrative: like a little bit of adrenaline rush the rest of the couple of hours I was working; I felt my heart was racing so checked, and my heart rate (HR) was in the upper 90s-110; I felt my heart was racing so checked, and my heart rate (HR) was in the upper 90s-110/ It kept doing that on and off, on and off until HR got around 120 at 11pm last night.; itchy; This is a spontaneous report from a contactable Other HCP reported for herself.   A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 28Dec2020 for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. The patient reported that she felt ok during the observation period (15 minutes) and like a little bit of adrenaline rush the rest of the couple of hours she was working.  When she got home, she felt her heart was racing so checked, and her heart rate (HR) was in the upper 90s-110.  Eventually it came down after hydrating herself.  It kept doing that on and off, on and off until HR got around 120 at 11pm last night. Benadryl helped.  She was itchy but her HR is back down to 76 and it seems that everything is clearing. The outcome of the events was reported as unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Malaise, Myalgia, Nausea
Clinical narrative: muscle aches; fatigue; nauseous/ almost vomiting; had a "brain fog" or was feeling unwell; had a "brain fog" or was feeling unwell; This is a spontaneous report from a contactable Other HCP reported for himself.   A 24-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on unknown date for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 1 day after getting the vaccine the patient experienced muscle aches and fatigue. Then on Sunday, he was nauseous, "almost vomiting," had a "brain fog" or was feeling unwell. The outcome of the events was reported as unknown.   Information on the lot/batch number has been requested.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site is moderately swollen and moderately painful; Injection site is moderately swollen and moderately painful; Range of motion is affected; This is a spontaneous report from a contactable nurse (patient). A 36-year-old female patient received the first dose of BNT162B2 (Lot Number: EK5730), via an unspecified route of administration in right arm, on 28Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history included seasonal allergies, and allergies to sulfa, kiwi, sunflower seeds, and herbal tea. The patient's concomitant medications included paracetamol (TYLENOL), loratadine (CLARITINE), ibuprofen (ADVIL), famotidine (PEPCID), ergocalciferol (VIT D), and ascorbic acid (VIT C). The patient previously took oseltamivir phosphate (TAMIFLU) and nickel and experienced allergies to both. No other vaccine was administered in four weeks. On 29Dec2020 at 11:00 AM, the injection site was moderately swollen and moderately painful and the patient's range of motion was affected (pending clarification). The patient was reporting this because she had never in her life had injection site swelling. The site was not itchy or red. There was no rash. It's just markedly swollen and painful. No treatment was given for the adverse events. The patient did not have COVID-19 prior to vaccination and the patient did not test for COVID-19 post-vaccination. The patient had not recovered from the events.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020; patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020. The patient wanted to know if it's safe for her to get the second dose of covid-19 vaccine scheduled for 07Jan2021. Outcome of the event was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient might not be completely excluded.
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Pain in extremity
Clinical narrative: having short term memory/can not recall things from 2 months ago; soreness in arm; This is a spontaneous report from a contactable Physician.   A female patient (Reporter's wife) of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on unknown date for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 29Dec2020 the patient experienced soreness in arm and at 4 o'clock pm she having short term memory, cannot recall things from 2 months ago. The outcome of the events was reported as unknown.   Information on the lot/batch number has been requested.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Paraesthesia, Vaccination site pain
Clinical narrative: Nausea; Chills; Injection site pain; Tingling in his arm; This is a spontaneous report from a non-contactable pharmacist.   A 29-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0140), via intramuscular, on 28Dec2020 at 13:15, at single dose for COVID-19 immunisation. Vaccine location was left arm. No relevant medical history and concomitant medications were provided. The patient was vaccinated at workplace clinic, age at vaccination was 29-year-old. No other vaccine was received in four weeks. On 29Dec2020, the patient reported normal side effects of nausea, chills, injection site pain. Patient also reported that he was experiencing tingling in his arm. No therapeutic measures were taken as result of the events. Pre-vaccination and post-vaccination COVID tests were not performed. The patient had not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic shock, Dizziness, Heart rate increased, Pharyngeal hypoaesthesia
Clinical narrative: anaphylactic shock/numb throat; high heart rate; light headed; anaphylactic shock/numb throat; This is a spontaneous report from a contactable consumer (patient himself).  A male patient of an unspecified age (reported as 39: unknown unit) received bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not reported), via an unspecified route of administration on 22Dec2020 at single dose, for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced anaphylactic shock, numb throat, high heart rate and light headed on an on 22Dec2020. The outcome of events was unknown.    Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: pain; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect from a contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced pain  (non-serious) on an unspecified date.  Therapeutic measures taken as a result of pain included 3 ADVIL. Caller reported taking 3 advil after receiving vaccine due to pain not related to vaccine, her pain was related to swimming.  The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently provided, a possible contributory role of vaccination with BNT162B2 in the development of the event pain cannot be excluded.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Rhinorrhea; This is a spontaneous report from a contactable nurse. A 48-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), intramuscular (arm left) on 23Dec2020 17:00 at single dose for Covid-19 immunization. The patient's medical history included obese and seasonal allergies. Concomitant medications included ibuprofen, acetaminophen, loratadine, calcium, vitamin c (ASCORBIC ACID), vitamin d3, probiotics, and fish oil. The patient previously took Nickel and experienced drug allergy. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rhinorrhea on 23Dec2020 (21:00). There was no treatment received for the adverse event. The outcome of event was recovered on an unspecified date. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on form arms; This is a spontaneous report from a contactable healthcare professional. A 40-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140), at the age of 39-year-old, via an unspecified route of administration on 23Dec2020 at 02:30 at a single dose on the right arm for Covid-19 immunization. Medical history included diabetic type 1. Concomitant medications included insulin aspart (NOVOLOG) and levothyroxine sodium (SYNTHROID).  The patient experienced rash on "form arms" on 28Dec2020 at 07:00. The patient received diphenhydramine hydrochloride (BENADRYL) as treatment for the event. Outcome of the event was recovering. The event was assessed as non-serious by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; Headache; This is a spontaneous report from a contactable consumer (patient).  A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 29Dec2020 at single dose in right upper arm for COVID-19 immunisation. Medical history was none.  There were no concomitant medications. On 29Dec2020 the patient experienced nausea, vomiting and headache: patient worked at the hospital; 30-45 minutes after she received the vaccine, she got really nauseated. She was also vomiting and had a headache. She has stopped vomiting on 29Dec2020 (30 min before the report). Events were all non-serious. Patient recovered from vomiting on 29Dec2020; outcome of nausea and headache was not recovered. Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: soreness; tiredness; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced soreness and tiredness on an unspecified date. The outcome of the events was unknown.    Information on the lot/batch number has been requested
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Experienced mild local site injection pain; This is a spontaneous report from a contactable physician. This report was received via a sales representative.    A 36 year-old male patient  received  bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on an unspecified date at  single dose for Covid-19 immunisation .  The patient medical history  and concomitant medications were not reported.  The patient experienced mild local site injection pain on an unspecified date with outcome of unknown.    No follow-up attempts are possible. Information about lot/Batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Illness, Pain
Clinical narrative: generalized pain/generalized body aches; shortness of breath; chills; sick; fever; feeling run down; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced generalized pain/generalized body aches, shortness of breath, chills, sick, fever, and feeling run down; all on 28Dec2020. The reporter didn't know if the patient had tested positive for COVID after receiving the COVID vaccine. This patient was not in the hospital at time of reporting. The outcome was unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: generalized pain/generalized body aches; shortness of breath; chills; sick; fever; feeling run down; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced generalized pain/generalized body aches, shortness of breath, chills, sick, fever, and feeling run down; all on 28Dec2020. The reporter didn't know if the patient had tested positive for COVID after receiving the COVID vaccine. This patient was not in the hospital at time of reporting. The outcome was unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID-19; tested positive for COVID-19; feeling sick; This is a spontaneous report from a consumer or other non hcp.    A male patient of an unspecified age received bnt162b2 (BNT162B2) vaccine, via an unspecified route of administration on  22Dec2020 at single dose for covid-19 immunisation .  The patient medical history and concomitant medications were not reported.  On 24Dec2020   the patient was sick and was  tested positive for covid-19, the outcome of the event was unknown.   Information about Lot/Batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes on my neck; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration in Dec2020 at single dose in arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Pfizer Vaccine last Tuesday in Dec2020 and today in Dec2020 the patient woke up with swollen lymph nodes on the neck, opposite side where the arm was injected. The outcome was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Heart rate, Heart rate increased, Nausea
Clinical narrative: Nausea; racing heart rate; restlessness; Dizziness; Shaking; breathlessness; This is a spontaneous report from a contactable consumer  reporting for herself.  A 28-years-old female patient received bnt162b2 (BNT162B2 ; Lot # EK9231) vaccine , via an unspecified route of administration on 27Dec2020 at single dose for Covid-19 immunisation .  Medical history included drug hypersensitivity to amoxicillin sodium  on an unknown date and unknown if ongoing.  There were no concomitant medications.   The patient experienced about one minute and a half after receiving the vaccine racing heart rate on 27Dec2020 with outcome of recovered , restlessness  on 27Dec2020 with outcome of recovered , dizziness  on 27Dec2020 with outcome of recovered , shaking on 27Dec2020 with outcome of recovered , breathlessness  on 27Dec2020 with outcome of recovering , nausea on 28Dec2020 with outcome of recovered.  The patient underwent lab tests and procedures which included heart rate: racing   on 27Dec2020.  The patient received diphenhydramine (BENADRYL) to treat dyspnea.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Restlessness, Tremor
Clinical narrative: Nausea; racing heart rate; restlessness; Dizziness; Shaking; breathlessness; This is a spontaneous report from a contactable consumer  reporting for herself.  A 28-years-old female patient received bnt162b2 (BNT162B2 ; Lot # EK9231) vaccine , via an unspecified route of administration on 27Dec2020 at single dose for Covid-19 immunisation .  Medical history included drug hypersensitivity to amoxicillin sodium  on an unknown date and unknown if ongoing.  There were no concomitant medications.   The patient experienced about one minute and a half after receiving the vaccine racing heart rate on 27Dec2020 with outcome of recovered , restlessness  on 27Dec2020 with outcome of recovered , dizziness  on 27Dec2020 with outcome of recovered , shaking on 27Dec2020 with outcome of recovered , breathlessness  on 27Dec2020 with outcome of recovering , nausea on 28Dec2020 with outcome of recovered.  The patient underwent lab tests and procedures which included heart rate: racing   on 27Dec2020.  The patient received diphenhydramine (BENADRYL) to treat dyspnea.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: I am like itchy all over in my the body; Rash; This is Spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Pfizer vaccine for COVID earlier on 29Dec2020 and few hours past, the patient got at around 3 O'clock and then at time of the report the patient was like itchy all over in the body and the patient had like rashes. The outcome of the events was unknown.  No follow-up attempts are possible. Information on lot/batch cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Headache, Nausea, Vomiting
Clinical narrative: dehydration; Headache; nausea; vomiting; This is a spontaneous report from a contactable physician. A 25-year-old female patient (no pregnancy) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, lot number: EL0142), intramuscularly at site of right arm on 28Dec2020 at single dose for COVID-19 immunization. Age at vaccination was 25-year-old. Medical history included COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19). The patient's concomitant medications were not reported. The patient experienced headache, nausea, vomiting, dehydration on 29Dec2020. Events were resulted in emergency room/department or urgent care. The patient received treatment (IV fluids, ondansetron (ZOFRAN), metoclopramide (REGLAN)) for the adverse event. Facility where the most recent COVID-19 vaccine was administered in hospital. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovering.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: some redness was noted at injection site; Pain at injection site; This is a spontaneous report from a contactable Physician (patient).  A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot number: EL0140), intramuscular in Left arm on  24Dec2020 at 11:45 am at single dose for COVID-19 immunisation .  Medical history was none.No known allergies to medications, food, or other products. There were no concomitant medications. On 24Dec2020 at 10:00 pm (as reported) the patient experienced pain at injection site and on 25Dec2020 some redness was noted at injection site; events were reported as non-serious and described as follows: pain at injection site, started 10 hours after vaccination (as reported), lasted 24 hours. Also some redness was noted at injection site a day after vaccination,  that self resolved in 2 days. Patient did not need to take any pain medication, no treatment given for the events. Patient recovered from the events in Dec2020.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, SARS-CoV-2 test
Clinical narrative: Headache; Chills; just really tired; achy; This is a spontaneous report from a contactable consumer. A 56-year-old female patient received bnt162b2 (BNT162B2; reported as Covid Vaccine Pfizer; batch/lot number: EH9899; expiration date: 31Mar2021), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 vaccination. Medical history included AFib (atrial fibrillation), high blood pressure and has 25 percent of her colon. The patient's concomitant medications were not reported. The patient reported that she a Pfizer shot yesterday (28Dec2020) which was clarified as Covid Vaccine Pfizer and today (29Dec2020) she was having some reactions to it, but they are not serious. The patient mentioned that she has like a headache and some chills and something like that which she hoped would go away by tomorrow (30Dec2020) and hoping that it doesn't last long. The patient mentioned that this was her first dose. When inquired on treatment, the patient mentioned that she was just really tired and achy and was just going to try sleep. The patient underwent lab tests and procedures which included Covid Rapid testing every single week [unspecified date] but no results were provided and last time she was tested was on last Tuesday (22Dec2020) with negative results. The outcome of the event headache and chills were not recovered while the outcome of the other events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Oropharyngeal pain, Sensation of foreign body
Clinical narrative: throat pain; increase body temperature; feels has something in throat; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 28Dec2020 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. After getting the vaccine on 28Dec2020, the patient asked if it is okay to get tested for Covid or if it might result in false positive. The patient reported that she has throat pain, increase body temperature and feels has something in her throat and keeps swallowing to clear it. She felt it yesterday (29Dec2020) and now is okay, only her throat was hurting. The outcome of event throat pain was not recovered, while the outcome of other events was recovered on an unspecified date.  Information on the batch/lot number has been requested.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: Headaches; This is a spontaneous report from a contactable Nurse (patient).  A 30-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE)  on 28Dec2020 at 13:30 at single dose in left arm  for COVID-19 immunisation. Medical history included COVID-19 on an unknown date (prior to vaccination the patient was diagnosed with COVID-19). Since the vaccination, the patient was not tested for COVID-19. No known allergies to medications, food or other products. There were no concomitant medications. The patient experienced headaches on 29Dec2020 at 05:00 am. Event was non serious . No treatment given and patient recovered from the event in Dec2020. Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dysgeusia, Influenza
Clinical narrative: Some flu symptoms; heavy; taste at the back of her throat; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration on an unspecified date in Dec2020 at a single dose for Covid-19 immunisation; and naproxen (NAPROSYN) via an unspecified route of administration on an unspecified date in Dec2020 at 2 dosage forms (DF) to prevent symptoms you could get with the vaccine. The patient's medical history and concomitant medications were not reported.  The patient reported that she received her first vaccine last night but two hours before, she took two naproxen to try to prevent the symptoms she heard you could get with the vaccine. She did feel some flu symptoms and heavy and a taste at the back of her throat. She was concerned that the naproxen may have had a negative effect on the vaccine. She wanted to know if there were any information. Outcome of the events were unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 antibody test positive
Clinical narrative: antibody/antigen testing; received vaccine on Monday  then tested positive last night; This is a spontaneous report from a contactable pharmacist (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date in Dec2020 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient called about antibody/antigen testing.  She tested negative on Sunday (Dec2020), received vaccine on Monday (Dec2020) then tested positive last night (Dec2020). She wanted to know if she truly has Covid or if it positive due to the vaccination. She gets tested every three day because she works in a long-term care facility. Outcome of the event was unknown.   Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dysgeusia, Feeding disorder, Feeling abnormal, Malaise
Clinical narrative: I developed a bitter taste; I am not able to eat; I felt so bad; I started coughing; I feel so sick and helpless; This is a spontaneous report from a contactable consumer (the patient), a front line worker.  A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/Lot number unknown, via an unspecified route of administration on 17Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 17Dec2020, a moment after vaccination, the patient experienced a bitter taste, was not able to eat, felt so bad, started coughing, felt so sick and helpless. The events were non-serious with outcome of unknown.  The information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Pain in extremity, Pruritus
Clinical narrative: headache; redness, soreness and itchiness on her arm that lasted a week; redness, soreness and itchiness on her arm that lasted a week; redness, soreness and itchiness on her arm that lasted a week; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age (reported as Age: 51; Unit: Unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number not provided), via an unspecified route of administration on 19Dec2020 at SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported.  For the first two days (on 21Dec2020) she had a headache, treated with paracetamol (TYLENOL) and headache went away. Then she developed redness, soreness and itchiness on her arm in Dec2020 that lasted a week.  This week these side effects have been more intermittent. She queried if it was okay to receive second dose on 08Jan2021. The patient recovered from the events in Dec2020.  Information on the batch/lot number has been requested.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: Left deltoid was sore initially, then pain progressed upward into left neck up to just under left ear; Left deltoid was sore initially, then pain progressed upward into left neck up to just under left ear; Also felt a little stiffness in that neck area; This is a spontaneous report from a contactable nurse, the patient.  A 62-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number EH9899) via an unspecified route of administration, in the left arm, on 19Dec2020 at 07:00 AM (at the age of 62-year-old) as a single dose for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medication taken within two weeks of vaccination included fish oil (OMEGA 3 FISH OIL), calcium carbonate, colecalciferol (VITAMIN D 2000). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Dec2020, at 08:00 AM, the patient experienced left deltoid was sore initially, then pain progressed upward into left neck up to just under left ear, she also felt a little stiffness in that neck area. The neck pain lasted 24 hours. The events were reported as non-serious. The patient did not receive any treatment for left deltoid was sore initially, then pain progressed upward into left neck up to just under left ear, she also felt a little stiffness in that neck area. The clinical outcome of the events left deltoid was sore initially, then pain progressed upward into left neck up to just under left ear, she also felt a little stiffness in that neck area was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Nausea, Pain, SARS-CoV-2 test
Clinical narrative: Nausea; body aches; headache; unable to sleep; This is a spontaneous report from a non-contactable nurse, the patient. A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number Eh9899) solution for injection in the left arm on 29Dec2020 at 14:00 (at the age of 35-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included asthma, pituitary adenoma, IBS (irritable bowel syndrome) and COVID (prior to vaccination). Concomitant medications were unknown. Past drug history included known allergies: ciprofloxacin hydrochloride (CIPRO). The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. In Dec2020, the patient experienced nausea, body aches, headache and unable to sleep. No treatment was provided for the events nausea, body aches, headache and unable to sleep. The outcome of the events nausea, body aches, headache and unable to sleep was recovering. Since the vaccination, the patient has been tested for COVID-19 via nasal swab on 30Dec2020 and result was pending.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Left hand feels sleepy; This is a spontaneous report from a contactable  health care professional nurse, the patient.  A 29-years-old non-pregnant female patient (nurse) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE); Lot Number: EK5730), intramuscular in the left arm on 30Dec2020 at 14:00 as a single dose, for COVID-19 vaccination. The patient had no known medical history or allergies. Concomitant medication included amoxicillin (AMOXICILLIN).  No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 30Dec2020 at 16:45, the patient experienced left hand feels sleepy. No Treatment was given for the event. The clinical outcome of left hand feels sleepy was not recovered.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Sensation of foreign body, Swelling face
Clinical narrative: swelling or mask like feeling to face with sensation changes (mild numbness) to face(both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands; swelling or mask like feeling to face with sensation changes (mild numbness) to face(both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands; swelling or mask like feeling to face with sensation changes (mild numbness) to face(both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands; swelling or mask like feeling to face with sensation changes (mild numbness) to face(both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands; swelling or mask like feeling to face with sensation changes (mild numbness) to face(both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands; This is a spontaneous report from a contactable nurse, the patient.  A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: ek5730, via an unspecified route of administration on 30Dec2020 at 12:00 (at the age of 51 years old) as a single dose in the right arm for COVID-19 vaccination.  Medical history included lupus from an unknown date, and allergy to Celebrex (itching).  The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included hydroxychloroquine sulfate (PLAQUENIL), levothyroxine, vitamin D3, and zinc, all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The vaccine was given at a hospital. On 30Dec2020 at 14:30, the patient experienced swelling or mask like feeling to face with sensation changes (mild numbness) to face (both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands. The patient received treatment for the events which included Pepcid, Benadryl and prednisone. The clinical outcome of swelling or mask like feeling to face with sensation changes (mild numbness) to face (both sides), tongue, lips and feeling of lump in throat; also same changes in sensation to fingers on both hands was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness, Nasopharyngitis
Clinical narrative: having a little bit of like a flu, don't know if it's like a cold; having a little bit of like a flu, don't know if it's like a cold; This is a spontaneous report from a contactable consumer, the patient. This patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) via an unspecified route of administration on 17Dec2020 as a single dose for COVID-19 vaccination. The patient's medical history was not reported. On an unspecified date in Dec2020, the patient experienced having a little bit of like a flu, don't know if it's like a cold. Limited information was available. The clinical outcome of the flu like illness and a cold was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Pruritus, Rash, Swelling
Clinical narrative: Rash; Inflammation; Swelling; Itchy; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer, the patient. This female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 vaccination. The patient's medical history and concomitant medication were not reported. On an unspecified date, the patient experienced a rash, inflammation, swelling and itchy after receiving the vaccine. She stated it was not uncommon for her to get. The patient wanted to know if she could take a Benadryl. Limited information was available. The clinical outcome of rash, inflammation, swelling and itchy was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 101.8 (unit not reported); This is a spontaneous report from a contactable consumer reported for herself. This female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 31Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a fever of 101.8 (unit not reported) that initially did not improve with aspirin or Tylenol. Temperature is currently 100.6. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Asthenia
Clinical narrative: weakness; This is a spontaneous report from a contactable consumer. An 88-year-old female patient  to received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified at a single dose for covid-19 immunisation, apixaban (ELIQUIS), via an unspecified route of administration from an unspecified date and ongoing at an unknown dose and frequency for an unspecified indication. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced weakness. It was further reported that patient got the first shot scheduled to get the second on 08Jan2020.  The patient had weakness from the shot and would like to known how long will the weakness last. The action taken in response to the event for apixaban was dose not changed. The outcome of the event was unknown.  Information about lot/batch number is requested
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Little cough; This is a spontaneous report from a contactable Nurse.  A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 20Dec2020 to 20Dec2020 single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced little cough on an unspecified date. The action taken in response to the event for BNT162B2 was not applicable. The outcome was recovered  Information on the lot/batch number has been requested.
Sex: F
Vaccine: FLUR4
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node on left side of neck; Initial information was received on 09-Nov-2020 regarding an unsolicited valid non-serious case from a consumer/non-hcp (healthcare professional).  This case involves female patient who experienced swollen lymph node on left side of neck (lymphadenopathy), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.  On 19-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number and expiration date were not reported) via unknown route in the right arm for prophylactic vaccination.  On 21-Oct-2020, the patient developed a non-serious swollen lymph node on left side of neck (lymphadenopathy), two days following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the event was unknown  at the time of reporting.  There will be no information on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: a lttle soreness in arms; Initial information regarding an unsolicited valid non-serious case was received from a non-health care professional via social media on 14-Dec-2020.  This case involves a patient of an unknown demographics who had a little soreness in arms (pain in extremity), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, past vaccinations, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient had a little soreness in arms (pain in extremity), (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.   No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Age: 24.0
Sex: F
Vaccine: CHOL, DT, TTOX, UNK
Symptoms: Pyrexia, Seizure
Clinical narrative: seizure; high fever; Initial information was received on 29-Dec-2020 regarding an unsolicited valid serious case from a consumer(patient) via other company.  This case involves a 24-year-old female patient who experienced seizure and high fever (pyrexia), while she received TETANUS TOXOID, DIPHTHERIA TOXOID, TYPHOID VACCINE and CHOLERA VACCINE.  Medical history, medical treatment, concomitant medications, vaccination and family history were not provided. At the time of the event, the patient had ongoing latex allergy (Rubber sensitivity) and injectable Iodine allergy.  On an unknown date, the patient received a dose of each suspect TYPHOID VACCINE produced by unknown manufacturer and suspects DIPHTHERIA TOXOID, TETANUS TOXOID and CHOLERA VACCINE not produced by Sanofi Pasteur (lot number and expiry date not reported) all vaccines via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious seizure and high fever (pyrexia) 6 hours following the administration of TYPHOID VACCINE, DIPHTHERIA TOXOID, TETANUS TOXOID and CHOLERA VACCINE. The patient was hospitalized for this event. (hospitalization duration 4 days). The event seizure was assessed as medically significant.  It was reported that, the patient having previous reactions to vaccines when she was 24 years old prior to trip and doctors told during hospitalization that she should not have received all four vaccines at the same time. Reporter asked if she can receive the COVID-19 vaccine, she also told that (this whole thing has been a waste of her time).  Other relevant laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for both the events.  Information on the lot number was requested.; Sender's Comments: This case concerns a 24-year-old female patient who experienced seizure and pyrexia after vaccination with TETANUS TOXOID, DIPHTHERIA TOXOID, TYPHOID VACCINE and CHOLERA VACCINE. The time to onset is compatible. The patient has allergies to latex and injectable iodine. Further information regarding medical condition at the time of vaccination, previous vaccinations and laboratory investigations excluding alternative etiologies is needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed.